United Kingdom

Manas Mishra

Lilly's Elanco animal health unit's IPO priced at $24/share

19 Sep 2018

The initial public offering of Eli Lilly Co's animal health unit, Elanco, was priced above the expected range at $24 per share on Wednesday, giving the company a market capitalization of $8.55 billion.

Japan's Eisai sets price tag of about $17,000 on liver cancer drug (Aug. 16)

17 Aug 2018

(This version of the August 16th story corrects to change drug price in headline, first bullet, paragraphs 1 and 3 after company corrects it to $16,970 from $15,970)

Aridis' shares rise in muted market debut

14 Aug 2018

Biotechnology company Aridis Pharmaceuticals Inc rose as much as 5.4 percent to $13.70 in its U.S. market debut on Tuesday, joining a host of other small-cap biotechs that have gone public this year.

FDA declines to approve Pain Therapeutics' opioid drug, shares plunge

06 Aug 2018

The U.S. Food and Drug Administration declined to approve Pain Therapeutics Inc's abuse-deterrent opioid treatment Remoxy for the fourth time, sending the company's shares down 35 percent to a record low.

Merck profit beats, but Keytruda sales fail to impress

27 Jul 2018

Merck & Co beat quarterly profit estimates on Friday as sales of its blockbuster drug Keytruda overtook rival Bristol-Myers Squibb's Opdivo, but that was not enough for investors who expected bigger gains in market share for the cancer therapy.

Allergan lifts earnings target, says no drug price hikes this year

26 Jul 2018

Drugmaker Allergan Plc raised its yearly earnings forecast on Thursday thanks to rising sales of mainstay product Botox, and said it did not expect to increase drug prices this year.

Hospital operator HCA raises forecast on higher patient admissions

25 Jul 2018

U.S. hospital operator HCA Healthcare Inc raised its full-year earnings forecast as higher-than-expected patient admissions lifted second-quarter profit by 25 percent, sending its shares up 7 percent.

Biogen easily tops Street estimates on Spinraza sales, raises forecast

25 Jul 2018

Biogen Inc reported far better-than-expected second quarter profit on Tuesday, driven by strong demand of its Spinraza muscle disease treatment, and the U.S. biotech company raised its full-year profit forecast.

Danaher's dental spinoff plan, profit beat push shares higher

19 Jul 2018

Danaher Corp said on Thursday it would spin off its dental unit into a publicly traded company, as the medical equipment maker seeks to revitalize a struggling business.

Pfizer-Lilly pain drug meets late-stage trial goals

18 Jul 2018

An experimental osteoarthritis drug developed by Pfizer Inc and Eli Lilly and Co achieved its main goal of lowering pain in a late stage trial, the companies said on Wednesday, potentially offering a safer alternative to opioids.

World News